FDA Drug Application (022525) for NAMENDA XR by FOREST LABS LLC

Back to FDA Applications sponsored by FOREST LABS LLC

Application Number022525
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage7MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNAMENDA XR
Active IngredientMEMANTINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient MEMANTINE HYDROCHLORIDE4


Back to FDA Applications sponsored by FOREST LABS LLC